Published in Am J Gastroenterol on October 02, 2012
Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol (2016) 1.17
Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis. J Neurogastroenterol Motil (2013) 1.13
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Common Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.88
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. Am J Gastroenterol (2015) 0.80
Antireflux endoluminal therapies: past and present. Gastroenterol Res Pract (2013) 0.78
Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterol J (2015) 0.78
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol (2016) 0.77
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Ther Adv Chronic Dis (2013) 0.76
Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil (2016) 0.75
Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics. Dig Dis Sci (2017) 0.75
Belching in Irritable Bowel Syndrome: An Impedance Study. J Neurogastroenterol Motil (2016) 0.75
Clinical and Histologic Mimickers of Celiac Disease. Clin Transl Gastroenterol (2017) 0.75
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol (2012) 4.78
Functional Dyspepsia. N Engl J Med (2015) 3.66
Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2012) 2.46
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol (2011) 2.19
Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies. Am J Gastroenterol (2013) 2.18
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
Initial management of dyspepsia in primary care: an evidence-based approach. Br J Gen Pract (2013) 1.90
Direction of the brain--gut pathway in functional gastrointestinal disorders. Gut (2012) 1.43
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease. Gut (2010) 1.41
Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.32
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 1.24
Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Am J Gastroenterol (2011) 1.09
Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.06
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis (2013) 1.04
Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol (2015) 0.89
Diagnosis and treatment of irritable bowel syndrome. Discov Med (2011) 0.88
Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same. Gastroenterol Clin North Am (2011) 0.82
Redundant data in the meta-analysis on Helicobacter pylori eradication. Ann Intern Med (2009) 0.82
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol (2011) 0.80
Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience. World J Gastroenterol (2013) 0.79
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience. J Crohns Colitis (2011) 0.78
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2009) 0.78
Efficacy of traditional chinese medicine in functional constipation. Am J Gastroenterol (2011) 0.78
Long-term efficacy and safety of azathioprine in ulcerative colitis. J Crohns Colitis (2015) 0.77
"Power" of selective serotonin reuptake inhibitors in irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 0.76
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Ther Adv Chronic Dis (2013) 0.76
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience. J Crohns Colitis (2011) 0.75
GERD: Is laparoscopic surgery cost-effective? Nat Rev Gastroenterol Hepatol (2009) 0.75
Overlap among the functional gastrointestinal disorders. Am J Gastroenterol (2010) 0.75
Don't forget about constipation with opioid treatment of chronic non-cancer pain. BMJ (2013) 0.75
Disease activity and venous thromboembolism in inflammatory bowel disease. Lancet (2010) 0.75
Bran and irritable bowels. Bran's deleterious effects: much ado about nothing. BMJ (2009) 0.75
Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated? Dig Dis Sci (2010) 0.75
Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome. Expert Rev Anti Infect Ther (2010) 0.75
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice. Gastroenterology (2009) 0.75
Clopidogrel with or without omeprazole in coronary disease. N Engl J Med (2011) 0.75
Treatment of chronic gastro-oesophageal reflux disease. BMJ (2009) 0.75
Functional Dyspepsia. N Engl J Med (2016) 0.75
Treatment of Helicobacter pylori in Latin America. Lancet (2012) 0.75
Reply to Machicado JD, Villafuerte-Galvez J, Marcos LA, Prevalence of irritable bowel syndrome in South America. Clin Gastroenterol Hepatol (2012) 0.75
Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome. Am J Gastroenterol (2011) 0.75
VSL#3 and remission in active ulcerative colitis: larger studies required. Am J Gastroenterol (2011) 0.75
Helicobacter pylori eradication. Lancet (2011) 0.75
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation? Inflamm Bowel Dis (2016) 0.75
Constipation in adults. BMJ Clin Evid (2015) 0.75
A patient with chronic diarrhea of unknown cause. Clin Gastroenterol Hepatol (2012) 0.75
Faecal microbiota transplantation for <em>Clostridium difficile</em>-associated diarrhoea: a systematic review of randomised controlled trials. Med J Aust (2017) 0.75
The Glasgow Prognostic Score at the Time of Palliative Esophageal Stent Insertion is a Predictive Factor of 30-Day Mortality and Overall Survival. J Clin Gastroenterol (2016) 0.75
Symbiotics in irritable bowel syndrome--better than probiotics alone? Curr Opin Clin Nutr Metab Care (2015) 0.75